A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer

NCT04486378 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

327

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer Stage II
Colorectal Cancer Stage III

Interventions

DRUG: RO7198457 intravenous (IV)
OTHER: Observational group (no intervention)

Sponsor

BioNTech SE

Collaborators

[object Object]